• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病中的胃功能障碍:新兴技术与药理学

Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology.

作者信息

Szarka Lawrence A, Camilleri Michael

机构信息

Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), College of Medicine, Mayo Clinic, Rochester, Minnesota.

出版信息

J Diabetes Sci Technol. 2010 Jan 1;4(1):180-9. doi: 10.1177/193229681000400123.

DOI:10.1177/193229681000400123
PMID:20167183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2825640/
Abstract

Gastroparesis and other types of gastric dysfunction result in substantial morbidity in diabetes patients. The pathophysiology of these disorders is incompletely understood. This article reviews techniques applicable to the assessment of gastric function in diabetes patients, including the measurement of emptying, accommodation, and contractility. Available treatment options are also reviewed, including novel yet unapproved serotonin 5-HT(4) agonist pharmacological treatments, as well as the role of endoscopic, surgical, and device treatments of gastroparesis.

摘要

胃轻瘫及其他类型的胃功能障碍在糖尿病患者中导致了相当高的发病率。这些病症的病理生理学尚未完全明了。本文综述了适用于评估糖尿病患者胃功能的技术,包括胃排空、胃容纳及胃收缩性的测量。还综述了现有的治疗选择,包括新型但尚未获批的5-羟色胺5-HT(4)激动剂药物治疗,以及胃轻瘫的内镜、手术和器械治疗的作用。

相似文献

1
Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology.糖尿病中的胃功能障碍:新兴技术与药理学
J Diabetes Sci Technol. 2010 Jan 1;4(1):180-9. doi: 10.1177/193229681000400123.
2
[Motility disorders and gastric emptying in diabetes mellitus. Current diagnostics and treatment].[糖尿病中的运动障碍与胃排空。当前的诊断与治疗]
Vnitr Lek. 2011 Apr;57(4):351-5.
3
Diabetic gastroparesis: recent insights into pathophysiology and implications for management.糖尿病性胃轻瘫:发病机制的最新认识及其对治疗的影响。
Expert Rev Gastroenterol Hepatol. 2013 Feb;7(2):127-39. doi: 10.1586/egh.12.82.
4
Measurement of gastric emptying in diabetes.糖尿病患者胃排空的测量
J Diabetes Complications. 2014 Nov-Dec;28(6):894-903. doi: 10.1016/j.jdiacomp.2014.06.005. Epub 2014 Jun 17.
5
Diabetic gastroparesis: functional/morphologic background, diagnosis, and treatment options.糖尿病性胃轻瘫:功能/形态学背景、诊断及治疗选择
Curr Diab Rep. 2014;14(9):527. doi: 10.1007/s11892-014-0527-8.
6
Management of diabetic gastroparesis.糖尿病性胃轻瘫的管理。
Saudi J Gastroenterol. 2011 Mar-Apr;17(2):97-104. doi: 10.4103/1319-3767.77237.
7
[Gastrointestinal complications of diabetes mellitus--an overview].[糖尿病的胃肠道并发症——综述]
MMW Fortschr Med. 2009 Oct 29;151(44):45-8.
8
[Diabetic gastroparesis and gastropathy].[糖尿病性胃轻瘫和胃病]
Vnitr Lek. 2004 Nov;50(11):867-72.
9
Ameliorating effects and mechanisms of electroacupuncture on gastric dysrhythmia, delayed emptying, and impaired accommodation in diabetic rats.电针对糖尿病大鼠胃节律紊乱、排空延迟和顺应性受损的改善作用及其机制。
Am J Physiol Gastrointest Liver Physiol. 2010 Apr;298(4):G563-70. doi: 10.1152/ajpgi.00252.2009. Epub 2010 Jan 21.
10
[Gastric emptying disorders in diabetic gastroparesis].
Dtsch Med Wochenschr. 1988 Jun 16;113(24):988-91. doi: 10.1055/s-2008-1067756.

引用本文的文献

1
Diagnostic Modalities Used in Diagnosing Gastroparesis: A Clinical Review.用于诊断胃轻瘫的诊断方法:一项临床综述。
Cureus. 2022 Oct 21;14(10):e30540. doi: 10.7759/cureus.30540. eCollection 2022 Oct.
2
Role of sex hormones in gastrointestinal motility in pregnant and non-pregnant rats.性激素在妊娠和未妊娠大鼠胃肠动力中的作用
World J Gastroenterol. 2016 Jul 7;22(25):5761-8. doi: 10.3748/wjg.v22.i25.5761.
3
Diagnostic assessment of diabetic gastroparesis.糖尿病性胃轻瘫的诊断评估
Diabetes. 2013 Aug;62(8):2667-73. doi: 10.2337/db12-1706.
4
Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.系统性硬化症患者液体负荷后胃动力障碍:超声研究。
Rheumatol Int. 2012 May;32(5):1219-23. doi: 10.1007/s00296-010-1779-5. Epub 2011 Jan 22.

本文引用的文献

1
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation.在健康和便秘人群中,Velusetrag(TD-5108)对胃肠道转运和肠道功能的影响及其药代动力学。
Neurogastroenterol Motil. 2010 Jan;22(1):42-9, e7-8. doi: 10.1111/j.1365-2982.2009.01378.x. Epub 2009 Aug 18.
2
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.胃饥饿素在胃肠道疾病中的作用及治疗途径。
Nat Rev Gastroenterol Hepatol. 2009 Jun;6(6):343-52. doi: 10.1038/nrgastro.2009.72.
3
Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis.放射性核素胃排空延迟研究可预测有胃轻瘫症状的糖尿病患者的发病情况。
Gastroenterology. 2009 Aug;137(2):445-52. doi: 10.1053/j.gastro.2009.04.055. Epub 2009 May 4.
4
Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents.三维超声测量健康成人和青少年胃容积的可行性及应用
J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):287-93. doi: 10.1097/mpg.0b013e318189694f.
5
The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006.1996年至2006年明尼苏达州奥尔姆斯特德县胃轻瘫患者的发病率、患病率及转归情况。
Gastroenterology. 2009 Apr;136(4):1225-33. doi: 10.1053/j.gastro.2008.12.047. Epub 2008 Dec 24.
6
Methods for measurement of gastric motility.胃动力测量方法。
Am J Physiol Gastrointest Liver Physiol. 2009 Mar;296(3):G461-75. doi: 10.1152/ajpgi.90467.2008. Epub 2009 Jan 15.
7
The stomach in diabetes: from villain to ally.糖尿病中的胃:从“反派”到“盟友”。
Clin Gastroenterol Hepatol. 2009 Mar;7(3):285-7. doi: 10.1016/j.cgh.2008.10.031. Epub 2008 Nov 6.
8
Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans.应用磁共振成像测量人体空腹和餐后容量。
Neurogastroenterol Motil. 2009 Jan;21(1):42-51. doi: 10.1111/j.1365-2982.2008.01194.x. Epub 2008 Oct 6.
9
The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.TD-5108的体外药理学特性,一种具有高内在活性的选择性5-羟色胺(5-HT)4受体激动剂。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378(1):125-37. doi: 10.1007/s00210-008-0282-y. Epub 2008 Apr 16.
10
The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.TD-5108是一种具有高内在活性的选择性5-羟色胺(5-HT)4受体激动剂,其体内胃肠道活性。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378(1):139-47. doi: 10.1007/s00210-008-0281-z. Epub 2008 Apr 12.